| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.8M | -20.3% |
| SG&A Expense | $20.7M | -21.5% |
| Operating Income | -$67.1M | -41.2% |
| Net Income | -$66.0M | -39.6% |
| EPS (Basic) | -$5.86 | -39.2% |
| EPS (Diluted) | -$5.86 | -39.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.1M | -32.5% |
| Short-term Investments | $60.2M | +8.5% |
| Current Assets | $86.1M | -7.5% |
| Total Assets | $113.3M | -34.4% |
| Current Liabilities | $5.7M | +33.6% |
| Total Liabilities | $11.2M | +4.9% |
| Stockholders' Equity | $102.1M | -37.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.5M | +23.3% |
| Capital Expenditures | $120K | -79.9% |
| Investing Cash Flow | $14.9M | +115.2% |
| Financing Cash Flow | -$90K | +60.5% |
| Free Cash Flow | -$26.6M | +24.3% |